Timeline
hVIVO to run pivotal Phase III whooping cough human challenge trial for ILiAD
Avacta demonstrates AVA6103 outdelivers Enhertu and reveals dual‑payload in vivo data
CRISM Therapeutics shows 58% tumour reduction with Docetaxel-ChemoSeed
AstraZeneca's Ultomiris meets primary endpoint in IgAN Phase III
TheraCryf manufactures clinical-grade Ox‑1
The Premarket Brief: GSK wins China approval for Blenrep in myeloma, Renishaw, Mulberry, Plus500, Supreme, Nanoco, ATOME, Smarter Web Company, Angus Energy
AstraZeneca reports tozorakimab cuts COPD exacerbations in Phase III MIRANDA
CelLBxHealth partners with The Royal Marsden on 200‑patient CTC study
GSK wins China approval for Blenrep in 2L+ multiple myeloma
Poolbeg Pharma says TOPICAL trial gets greenlight
GSK completes acquisition of 35Pharma for $950m
hVIVO revenue slides, strategy pivot offsets market hit
hVIVO inks influenza human challenge trial with Traws Pharma
Trellus renews Pfizer licence for IBD app content
Solvonis secures another US patent for PTSD programme
Avacta to raise c.£10m via equity placing
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.